This role for C3a and C5a has been shown in different cancer types, in the form of promoting angiogenesis, inhibiting anti-tumor immune responses and by triggering tumorigenic, survival and anti-apoptotic pathways in tumor cells (141). This evidence concerns the gene C5 and neoplasm.